Skip to main content
OA

obvioTec AG

The startup offers a quality control technology that utilizes advanced analytical methods to enhance testing accuracy in the life sciences sector. This technology accelerates the control and release processes while reducing operational costs, thereby improving overall product safety and compliance in pharmaceutical manufacturing.

Zollikon, SwitzerlandFounded 201814500+ followers
Updated 3 months ago

Funding

$5.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Traditional quality control methods in pharmaceutical manufacturing, such as visual inspection and weighing, often fail to detect critical defects or missing components within sealed packaging. These limitations can lead to safety risks, product recalls, and increased operational costs. Current inspection methods also struggle with unstable lighting conditions and the inability to penetrate opaque materials.

Solution

Obviotec provides non-destructive quality control solutions for the pharmaceutical and life science industries, utilizing Gigahertz (GHz) and Terahertz (THz) technologies combined with machine learning. Their inline inspection systems and standalone solutions offer real-time detection of missing components, defects, and foreign particles within drug containment solutions and packaged pharmaceuticals, without compromising the integrity of the samples. The technology creates a digital twin of each product for 100% traceability and serialization, ensuring product safety and regulatory compliance. Obviotec's systems can be integrated into existing production lines and are GMP-compliant.

Target Audience

Obviotec's primary customers are pharmaceutical manufacturers and their suppliers, particularly those producing combination products, injectable drugs, vials, pre-filled syringes, and autoinjectors.

Features

  • Inline inspection systems for 100% end-of-line inspection of combination products in secondary packaging at production speeds up to 120 packages per minute.
  • GHz-based systems penetrate pharmaceutical secondary packaging, including multiple layers of paper, plastic, and carton.
  • THz-based systems detect small defects and foreign particles, such as glass, metal, and plastic, inside lyocakes and other solid matrices.
  • Detailed multi-slice scans capture multiple layered images of each product, ensuring comprehensive detection of all components.
  • Advanced detection algorithms for completeness verification of packaged pharmaceuticals.
  • Non-ionizing radiation ensures safety for both operators and samples.
  • Systems are independent of weight and lighting conditions.
  • Customizable and modular design for easy integration and scalability.
This profile is AI-generated and may contain inaccuracies.